
Yang (Mao) Mao-Draayer MD
Associate Professor, Neurology, University of Michigan Medical School
Join to view full profile
28595 Orchard Lake RdSte 200Farmington Hills, MI 48334
Phone+1 248-553-0010
Fax+1 248-553-5957
Dr. Mao-Draayer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Vermont Medical CenterResidency, Neurology, 2000 - 2003
Texas Tech University Health Sciences Center at LubbockInternship, Transitional Year, 1999 - 2000
Peking Union Medical CollegeClass of 1990
Certifications & Licensure
MI State Medical License 2012 - 2028
OK State Medical License 2024 - 2027
VT State Medical License 2000 - 2012
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Mechanistic Studies of Teriflunomide in RRMS Start of enrollment: 2018 Apr 17
Publications & Presentations
PubMed
- Autologous Hematopoietic Transplantation Reduces Brain Inflammatory and Axoglial Damage Biomarkers in Multiple Sclerosis.Laura A Cooney, Noha Lim, Kristina M Harris, Dawn E Smilek, Pradeepthi Bathala
Neurology(R) Neuroimmunology & Neuroinflammation. 2026-11-01 - Multimodal effects of CD40L blockade in multiple sclerosis: Insights from preclinical and clinical studies.Ismail Muwenda, Joshua S Mytych, Ekdanai Uawithya, Megan Reidy, Meerah Khan
Multiple Sclerosis. 2026-10-27 - Abatacept Reduces CD319+ (SLAMF7) Cytotoxic T Cells and Cytokine Production in Systemic Sclerosis.Mikel Gurrea-Rubio, Laura A Cooney, Kohei Maeda, Phillip L Campbell, Qi Wu
Arthritis & Rheumatology. 2026-08-20
Press Mentions
OMRF Receives $3.8 Million to Study Autoimmune DiseasesAugust 12th, 2024
OMRF Welcomes New MS Neurologist-ScientistJune 6th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: